Login / Signup

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.

Yiwang XuAhmad MiremadiAlexander LinkPeter MalfertheinerRebecca C FitzgeraldJan Bornschein
Published in: Journal of clinical pathology (2019)
Assessment of serum PG1 could be combined with a test for Barrett's oesophagus to identify additional patients requiring endoscopy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • squamous cell carcinoma
  • peritoneal dialysis
  • prognostic factors